Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04340505 · ClinicalTrials.gov registry record
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 30
- Enrollment target
NCT04340505 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 30 participants.
The verdict
NCT04340505 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
We will prospectively observe patients with uveitis who are either active or were recently active in the previous 6 months and are treated with the i-FA implant. All of the patients will have standard clinical exams at baseline and image quantification of their inflammation using OCT, OCTA and UWFFA (if needed). At baseline, ETDRS vision will be measured. Patients will be followed for 12 months months. During follow-up repeat imaging will be performed along with standard examinations, visual acuity and contrast sensitivity measurements. At the final visit, all tests will be repeated. Data collected will be analyzed using statistical software package. Correlations between changes in imaging quantification of inflammation scores and changes in visual acuity, clinical grades of inflammation, and contract sensitivity will be calculated.
Interventions
- DRUG Fluocinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-08-08 |
| Est. Completion | 2026-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04340505
The ClinicalTrials.gov registry entry for NCT04340505 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone Acetonide is the first listed.
NCT04340505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04340505 about?
NCT04340505 is a clinical study titled "Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant". We will prospectively observe patients with uveitis who are either active or were recently active in the previous 6 months and are treated with the i-FA implant. All of the patients will have standard clinical exams at baseline and image quantification of their inflammation using OCT, OCTA and UWFFA...
What is the current status of trial NCT04340505?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-08-08. Estimated completion is 2026-02-01.
What interventions are being tested in trial NCT04340505?
The interventions under investigation include: Fluocinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT04340505?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.